title: [Cutaneous larva migrans in Turkey: an imported case report].
abstract: Cutaneous larva migrans (CLM) is a parasitic infection most commonly found in tropical and subtropical areas. However, with the ease and increase of foreign travel to many countries around the world, the infection is not limited to these areas. CLM is an erythematous, serpiginous infection with skin eruption caused by percutaneous penetration of the larvae to the skin. In this report, a case diagnosed as imported CLM after an Amazon trip and treated with albendazole was presented. A 36 year-old male patient admitted to infectious diseases clinic with intense itching, erythematous, raised, streaklike serpiginious eruptionand some redness at bilateral foot especially at the right foot for about one week. The patient was living in Turkey, and travelled to Brazil for an Amazon trip three months ago and the lesions began immediately after this occasion. CLM was diagnosed with the typical lesions in the patient and oral albendazole treatment 2 x 400 mg/day for 3 consecutive days was carried out with oral amoxicillin/clavulanat 3 x 1 g/day for the secondary bacterial infection. The patient responded very well to oral albendazole treatment with a result of a rapid improvementof pruritus in days and no side effect was observed during the treatment period.After discharge, during his controlit was seenthat the lesions were regressed with leaving hyperpigmentation. In cases with cutaneous larva migrans, diagnosis is often made by the presence of pruritic typical lesions and tunnels, travel story to endemic regions, the story of barefoot contact with sand and soil in these regions, and the sun tanning story on the beach. The lesions are often seen in the lower extremities, especially in the dorsal and plantar surface of the foot. Laboratory findings are not specific. Temporary peripheral eosinophilia can be seen and biopsy can be done to confirm the diagnosis but usually no parasite is seen in the histopathological examination. Contact dermatitis, bacterial and fungal skin infections and other parasitic diseases should be considered in differential diagnosis. For the treatment ivermectin 1 x 200 mg/kg single dose or albendazole 400 mg/day for three days is recommended. As a result, cutaneous larva migrans should be kept in mind especially in patients with a history of travel to endemic areas and a history of bare feet contact with sandy beaches and soil in this region and with itchy, red and serpiginous skin lesions.
authors.affiliation: Ankara Educational and Research Hospital, Department of Infectious Diseases, Ankara, Turkey. melihakarakoyun@mynet.com.
authors.forename: Meliha Çağla
authors.initials: MÇ
authors.lastname: Sönmezer
authors.forename: Şebnem
authors.initials: Ş
authors.lastname: Erdinç
authors.forename: Necla
authors.initials: N
authors.lastname: Tülek
authors.forename: Cahit
authors.initials: C
authors.lastname: Babür
authors.forename: Ayşe
authors.initials: A
authors.lastname: Büyükdemirci
authors.forename: Tuba
authors.initials: T
authors.lastname: İlgar
authors.forename: Günay
authors.initials: G
authors.lastname: Ertem
mesh_terms: D000284:Administration, Oral; D000328:Adult; D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D001493:Bathing Beaches; D001938:Brazil; D003937:Diagnosis, Differential; D005533:Foot Dermatoses / Q000188:drug therapy / Q000469:parasitology*; D006801:Humans; D007815:Larva Migrans / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D014195:Travel; D014421:Turkey
chemical_list: D000871:Anthelmintics; D015766:Albendazole